Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03063892 · ClinicalTrials.gov registry record · Phase 4

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

A Phase 4 study of Hip Fractures, sponsored by Gregory M Georgiadis MD.

Recruiting
Registry status
Phase 4
Development phase
200
Enrollment target
1
Study location

NCT03063892 is a Phase 4 study of Hip Fractures that is actively recruiting participants, run by Gregory M Georgiadis MD. The registered enrollment target is 200 participants, below the 608-participant average among 15 other Hip Fractures trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03063892, a Phase 4 study of Hip Fractures, is actively recruiting participants, sponsored by Gregory M Georgiadis MD.

RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available on its use in hip fracture patients. We hypothesize that the use of TXA preoperatively, perioperatively, and postoperatively will decrease blood loss and need for blood transfusion postoperatively.

Conditions Studied

Hip Fractures

Interventions

  • DRUG Tranexamic Acid (TXA)
  • DRUG Saline solution

Study Locations (1)

Ohio

  • ProMedica Toledo Hospital - Toledo

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2017-08-30
Est. Completion 2026-09-01
Phase Phase 4

Sponsor

Gregory M Georgiadis MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03063892

The ClinicalTrials.gov registry entry for NCT03063892 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 15 other Hip Fractures trials with a reported enrollment target (67% lower). The listed sponsor is Gregory M Georgiadis MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic Acid (TXA) is the first listed.

NCT03063892 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03063892 about?

NCT03063892 is a clinical study titled "Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion". Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research is available on its use in hip fracture patients. We hypothesize that the use of TXA preoperatively, perioperativ...

What is the current status of trial NCT03063892?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2017-08-30. Estimated completion is 2026-09-01.

What conditions does trial NCT03063892 study?

This clinical trial studies the following conditions: Hip Fractures.

What interventions are being tested in trial NCT03063892?

The interventions under investigation include: Tranexamic Acid (TXA) (DRUG), Saline solution (DRUG).

Who is sponsoring clinical trial NCT03063892?

This trial is sponsored by Gregory M Georgiadis MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03063892 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hip Fractures

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.